Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.

 

To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this link

 

The USD 4.2 billion (by 2030) financial opportunity within the biologics fill / finish services market has been analyzed across the following segments:

• Types of Primary Packaging Containers
• Ampoules
• Cartridges
• Syringes
• Vials

 

• Types of Biologics
• Peptides / proteins
• Antibodies
• Vaccines
• Cell therapies
• Gene therapies
• Viral products
• Oligonucleotides
• Others

 

• Company Size
• Small-sized
• Mid-sized
• Large / very large

 

• Scale of Operation
• Preclinical
• Clinical
• Commercial

 

• Key Therapeutic Areas
• Cancer
• Infectious diseases
• Autoimmune diseases
• Cardiovascular diseases
• Other indications

 

• Key Geographical Regions
• North America (US, Canada)
• Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
• Asia-Pacific (Japan, China, South Korea, India and Australia)

 

The Biologics Fill / Finish Services Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Advanced BioScience Laboratories (ABL)
• Albany Molecular Research (AMRI)
• Biocon
• BioPharma Solutions
• BioReliance
• Boehringer Ingelheim BioXcellence
• ChemPartner
• Emergent BioSolutions
• IDT Biologika
• Lonza
• LuinaBio
• Mycenax Biotech
• Patheon
• Recipharm
• Vetter Pharma
• WuXi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Competitive Landscape
 

5. Company Competitiveness Analysis
 

6. Biologics Fill / Finish Service Providers in North America: Company Profiles
 

7. Biologics Fill / Finish Service Providers in Europe: Company Profiles 
 

8. Biologics Fill / Finish Service Providers in Asia-Pacific: Company Profiles
 

9. Partnerships and Collaborations
 

10. Recent Expansions
 

11. Capacity Analysis
 

12. Demand Analysis
 

13. Biologics Manufacturing and Fill / Finish: Key Performance Indicator Analysis
 

14. Market Sizing and Opportunity Analysis

 

15. Future Growth Opportunities

 

16. Case Study: Robotic Systems in Fill / Finish Operations

 

17. Case Study: Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com